Previous 10 | Next 10 |
Amarin stock surpassed the 75% upside price target in Feb., only to fall from there. Unfavorable Patent ruling expected. Renewed upside for AMRN stock discussed. For further details see: Why Amarin Stock May Rise From Here
This surely won't be a week to remember for Amarin (NASDAQ: AMRN) . Following Monday's stinging Supreme Court loss regarding patent protection for its one and only commercialized drug, on Tuesday one of the company's rivals announced the launch of a new generic for that product. Ama...
arsenisspyros/iStock via Getty Images Amarin Corporation ([[AMRN]] -5.0%) is trading lower in morning hours amid reports that the Supreme Court has rejected the company’s bid revive Vascepa patents. More details to follow… For further details see: Amarin falls; unfavorable...
Will These Penny Stocks Continue to Show Momentum? Penny stocks are heating up. This is characterized by large intraday movements, and investors showing heightened bullish interest. While not all penny stocks are winners, it can be easy to find the best penny stocks to buy by fo...
7 Hot Penny Stocks For Your Watch List This Week Here we are at the start of a brand new week in the stock market. Penny stocks are at the top of mind for thousands of traders right now. Thanks to the excitement surrounding them, these cheap stocks continue growing in popularity. There ...
The following slide deck was published by Amarin Corporation plc in conjunction with this event. For further details see: Amarin Corporation (AMRN) Presents At Goldman Sachs 42nd Annual Global Healthcare Conference - Slideshow
The following slide deck was published by Amarin Corporation plc in conjunction with this event. For further details see: Amarin Corporation (AMRN) Presents At Jefferies Virtual Healthcare Conference - Slideshow
Amarin Corporation plc (AMRN) Goldman Sachs 42nd Annual Global Healthcare Conference June 08, 2021 10:30 AM ET Company Participants John Thero - CEO Karim Mikhail - SVP, Commercial Head Europe Conference Call Participants Paul Choi - Goldman Sachs Presentation Paul Choi Good morning. We'll co...
DUBLIN, Ireland and BRIDGEWATER, N.J., June 02, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of further insights into various potential mechanisms of action of icosapent ethyl and differences in biological actions of the unique form of eicos...
Amarin Corporation plc (AMRN) Jefferies Virtual Healthcare Conference June 2, 2021 9:30 AM ET Company Participants John Thero – President and Chief Executive Officer Karim Mikhail – Senior Vice President, Commercial Head-Europe Conference Call Participants Michael Yee – J...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...